Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Cook Incorporated Withdraws From TCT Conference in Washington, D.C. To Ensure Employee Safety and Ensure Delivery of Medical Supplies To Customers.


Business & Health/Medical Editors

BLOOMINGTON, Ind.--(BW HealthWire)--Sept. 11, 2001

Following today's terrorist attacks in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
 and Washington, D.C., Cook Incorporated has withdrawn from the Transcatheter Cardiovascular Therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
 (TCT TCT The Capital Times (Madison, WI newspaper)
TCT Transcatheter Cardiovascular Therapeutics
TCT The Coroner's Toolkit
TCT Trans Canada Trail
TCT Tcl Core Team
TCT Tsukuba College of Technology (Japan) 
) in the nation's capital.

"Cook Incorporated has a large number of employees and professional associates either presently in Washington for the TCT conference or planning to travel there tomorrow. In the interest of their safety and well-being, we have decided to withdraw our exhibit booth from the conference and allow our people to return home as soon as federal authorities determine that it is safe to travel," said Phyllis McCullough, chairman of Cook Incorporated. "In addition, we want to ensure that all Cook employees are available to service the nation's hospitals and medical clinics and help deliver any medical devices required to cope with the injuries caused by this national tragedy."

With international headquarters in Bloomington, Ind., privately held COOK(R) (www.cookgroup.com/) is a leading designer, manufacturer and global distributor of minimally invasive medical device technology for diagnostic and therapeutic procedures. Since its founding in 1963, COOK has been committed to product innovation, skilled hand-craftsmanship and unsurpassed customer satisfaction, earning the company global recognition among medical professionals. Cook Incorporated is acknowledged as an innovator in catheter technology, wire guides, introducer needles and sheaths, stents and stent-grafts, embolization embolization /em·bo·li·za·tion/ (em?bo-li-za´shun)
1. the process or condition of becoming an embolus.

2. therapeutic introduction of a substance into a vessel in order to occlude it.
 coils, drainage catheters, tissue-engineered medical biomaterials, vena cava filters Vena Cava Filter Definition

A vena cava filter is a device inserted into a major vein to prevent a blood clot from entering the lungs.
Purpose
, implanted cardiac lead extraction technology and other minimally invasive devices. More than 40 companies in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. , Europe, Canada, Australia and Asia design, produce, manufacture and distribute COOK brand medical devices to physicians and other medical professionals around the world.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Sep 11, 2001
Words:272
Previous Article:Alaska, Horizon Express Sympathy for Victims of Terrorist Attacks, Provide Information On Passengers' Reaccommodation.
Next Article:FDA Advisory Committee Panel Recommends Approval of ZEVALIN for Treatment of Certain Non-Hodgkin's Lymphomas.



Related Articles
FDA Food Code.
Radiance Schedules Conference Call for Wednesday, Oct. 18 to Discuss Clinical Results of BETTER and BRITE Studies.
Guidant and COOK Agree to Collaborate on Drug-Coated Stent Program.
Cook Incorporated to Release Drug-Eluting Coronary Stent Clinical Data Next Week.
Guidant Announces Significant Progress in its Multiple Programs for Drug-Coated Stents; Guidant Completes ACTION Clinical Trial Enrollment for FDA...
Guidant and Cook Announce Submission of FDA Filing to Begin U.S. Drug-Coated Stent Trial.
U.S. MAYORS BACK BIGGER FEDERAL ROLE AT AIRPORTS.
CEO to CEO.
Safety for profit: traffic light cameras questioned. (Citings).
Biophan's Next-Generation Technology to Be Showcased at International Transcatheter Cardiovascular Conference; Solutions to Enable MRI Visualization...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles